Utama › Kanser Kolorektal › Illinois › Chicago
Kajian klinikal Kanser Kolorektal di Chicago, IL
33 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Mengambil pesertaFasa 2
- University of Illinois, Chicago
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Mengambil peserta
- Northwestern Memorial Hospital, Chicago
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- University of Chicago Medical Center /ID# 279365, Chicago
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mount Sinai Hospital Medical Center, Chicago
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- dan 1 lagi
Family Communications After Genetic Testing
Mengambil pesertaSukarelawan sihat dialu-alukan
- Advocate Illinois Masonic Medical Center, Chicago
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Exelixis Clinical Site #26, Chicago
PRE-ISPY Phase I/II Oncology Platform Program
Mengambil pesertaFasa 1/2
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 2
- University of Chicago Medical Center /ID# 271688, Chicago
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Illinois Cancer Specialists, Chicago
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- Research Site, Chicago
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- University of Chicago, Chicago
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Mengambil pesertaFasa 3
- Northwestern University, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- Northwestern Medicine Cancer Center Old Irving Park, Chicago
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Mengambil pesertaFasa 2/3
- Local Institution - 0433, Chicago
Manipulation of the Gut Microbiome by a Standardized Preoperative Diet to Prevent Colorectal Cancer Recurrence and Metastasis Following Surgery
Mengambil pesertaFasa 1/2
- University of Chicago, Chicago
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Mengambil pesertaFasa 3
- University of Illinois Cancer Center, Chicago
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Clinical Study Site, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Mengambil pesertaFasa 3
- Insight Research Institute, Chicago
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Mengambil pesertaFasa 1/2
- Lurie Children's Hospital-Chicago, Chicago
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Mengambil pesertaFasa 2
- Research Site, Chicago
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Mengambil pesertaFasa 2
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center, Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- University of Chicago Medical Center /ID# 274742, Chicago
Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection
Mengambil pesertaKajian pemerhatian
- Northwestern University-Comprehensive Transplant Center, Chicago
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Mengambil pesertaFasa 1/2
- The University of Chicago Medical Center - Oncology, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Mengambil pesertaFasa 1
- Context Investigational Site, Chicago
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Mengambil pesertaKajian pemerhatian
- The University of Chicago Medical Center, Chicago
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Mengambil pesertaFasa 1/2
- University of Chicago Medical Center, Chicago
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- John H Stroger Jr Hospital of Cook County, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
Mengambil pesertaFasa 1/2
- University of Chicago, Chicago
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Mengambil pesertaFasa 4
- University of Chicago Medical Center, Chicago
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Mengambil pesertaKajian pemerhatian
- Advocate Illinois Masonic Medical Center, Chicago
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Mengambil pesertaKajian pemerhatian
- John H Stroger Jr Hospital of Cook County, Chicago
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
Mengambil pesertaFasa 2
- Northwestern University, Chicago
Kajian Kanser Kolorektal di bandar lain
- Houston, TX102 kajian
- New York City, NY77 kajian
- Nashville, TN69 kajian
- Boston, MA63 kajian
- Los Angeles, CA59 kajian
- Arlington, VA52 kajian
- St. Louis, MO50 kajian
- San Antonio, TX46 kajian
- Philadelphia, PA44 kajian
- Grand Rapids, MI40 kajian
- Baldwin Park, CA38 kajian
- Seattle, WA34 kajian
Kajian lain di Chicago
- Kanser Paru-paru Bukan Sel Kecil61 kajian
- Kanser Payudara58 kajian
- Kanser (semua jenis)51 kajian
- Kanser Metastatik45 kajian
- Kanser Prostat45 kajian
- Obesiti41 kajian
- Kanser Paru-paru41 kajian
- Kanser Ovari36 kajian
- Strok34 kajian
- Kegagalan Jantung31 kajian
- Berat Badan Berlebihan28 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.